ReviewJournal of animal science and biotechnology2026
Developmental Cellular Programming: stage-specific architecting muscle and adipose tissues for high-quality meat production.
Review in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The rising global demand for animal protein has driven intensive selection for rapid growth and leanness, often at the expense of meat quality and animal health. Achieving high-quality meat production with optimal intramuscular fat (IMF) and superior myofiber characteristics remains a major challenge in animal agriculture. Here, we propose a holistic conceptual framework termed Developmental Cellular Programming (DCP), which utilizes distinct developmental windows to precisely regulate skeletal muscle and adipose tissue formation in meat animals. Unlike traditional late-stage finishing strategies, the DCP framework operates as a coordinated, stage-specific pipeline: optimizing maternal nutrition during gestation to maximize prenatal myofiber hyperplasia and initiate adipocyte lineages; executing targeted neonatal interventions to drive microenvironment-mediated adipogenic precursor expansion and angiogenesis; and fine-tuning nutrient allocation during the finishing phase to control cellular hypertrophy and lipid deposition. Within this framework, vascularization is established as a critical, shared control point that coordinates multi-tissue niches to synchronize myofiber and adipocyte development. While advanced three-dimensional cell culture models, such as vascularized tissue organoids, have emerged as powerful platforms for high-throughput screening of key candidate metabolic modulators, bridging the gap to livestock production necessitates translating these cellular responses into whole-animal phenotypes. We propose that future research should focus on conducting in vivo animal trials to elucidate how various nutrients regulate muscle and adipose cell differentiation at specific developmental stages, thereby establishing precision nutritional strategies based on the DCP theory for high-quality meat production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.